Install
Biotech and pharma business news, with a focus on the science, people and money that drive the industry.
- 94articles · 30d
- 1+ day agolatest article
- Aug 17, 2026earliest in window
- 95%with images
- 86avg words
- health 56
- business 43
- biotech 35
- fda 28
- pharma 28
- biotechnology 26
- cancer 21
- drug development 21
- clinical trials 19
- type-newspost 19
- tmt newswire 16
- globenewswire 15
- pharmaceuticals 15
- stat+ 15
- biopharma 13
- markets 13
- oncology 13
- (midwest communications 12
- artificial intelligence 12
- business & health 11
- Health & Wellness 74
- Medical 63
- Science & Technology 31
- Health 30
- Economy, Business & Finance 27
- Finance & Business 21
- Business & Industrial 15
- Science & Nature 7
Please confirm you are human
This browser or connection looks automated. Press and continuously hold the control for 3 seconds to enable Google-hosted web results and, when separately allowed, AI-assisted answers.
A successful check enables 100 search requests. Interactive access does not authorize scraping, systematic collection, or reuse of search output.
News
Akeso details survival win for its PD-1xVEGF drug versus Keytruda
1+ day, 11+ hour ago (76+ words) Endpoints News Akeso details survival win for its PD-1xVEGF drug versus Keytruda Akeso and Summit Therapeutics claimed a key win over Keytruda at the start of September,…...
Exclusive: Cancer biotech TwoStep gets $62.5M to take twist on ADCs into clinic
5+ day, 1+ hour ago (92+ words) Endpoints News Exclusive: Cancer biotech TwoStep gets $62.5M to take twist on ADCs into clinic Pfizer and Merck KGaA’s venture groups are backing a nimble cancer startup tak…...
Tyra finds ray of sunshine in otherwise cloudy Phase 2 bladder cancer data
5+ day, 1+ hour ago (81+ words) Endpoints News Tyra finds ray of sunshine in otherwise cloudy Phase 2 bladder cancer data Tyra Biosciences wants to challenge Johnson & Johnson in a low-risk form of bladder cancer....
Inhibrx opens door to cancer vaccine combo for its OX40 agonist
6+ day, 1+ hour ago (154+ words) Endpoints News We value your privacy We use third-party cookies that help us analyze how you use this website and store your preferences. However, you can opt out of these cookies by checking "Do Not Sell or Store My Personal…...
BrainChild Bio gets $116M for pivotal trial of pediatric brain tumor CAR-T
6+ day, 1+ hour ago (81+ words) Endpoints News BrainChild Bio gets $116M for pivotal trial of pediatric brain tumor CAR-T A Seattle biotech trying to flip the script on CAR-T cell therapies — making them akin to…...
Roivant reports Phase 2 win for lung disease drug that it got from Bayer
6+ day, 2+ hour ago (151+ words) #ERS26: Roivant reports Phase 2 win for lung disease drug that it got from Bayer Endpoints News We value your privacy We use third-party cookies that help us analyze how you use this website and store your preferences. However, you can opt…...
FDA approves AstraZeneca’s oral SERD for breast cancer despite negative adcomm vote
6+ day, 19+ hour ago (82+ words) Endpoints News FDA approves AstraZeneca’s oral SERD for breast cancer despite negative adcomm vote AstraZeneca clinched an FDA accelerated approval for its oral SERD in certain…...
Novartis CAR-T deaths raise questions over acceptable autoimmune risk
1+ week, 4+ day ago (96+ words) Deaths in Novartis CAR-T trial force a reckoning over acceptable risk in autoimmune disease Endpoints News Deaths in Novartis CAR-T trial force a reckoning over acceptable risk in autoimmune disease…...
China deaths reignite debate about using viruses to deliver CRISPR therapies
1+ week, 4+ day ago (85+ words) Endpoints News China deaths reignite debate about using viruses to deliver CRISPR therapies The deaths of two children who received CRISPR therapies in China have rattled…...
ARPA-H awards $125M for manufacturing custom RNA therapies on demand
1+ week, 5+ day ago (84+ words) Endpoints News ARPA-H awards $125M for manufacturing custom RNA therapies on demand The dream of making personalized genetic medicines at a moment’s notice…...